Back
Context Therapeutics, Inc. Stock Predictions
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now
Buy
74
CNTX
Context Therapeutics, Inc.
Last Price:
$2.46
Seasonality Move:
-0.89%
7 Day Trial
ALL ACCESS PASS
$
7
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis NowContext Therapeutics, Inc. Stock Forecast
-
Is Context Therapeutics, Inc. Stock Undervalued?The current Context Therapeutics, Inc. [CNTX] share price is $2.40. The Score for CNTX is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
-
CNTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Context Therapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
Context Therapeutics, Inc. Stock Rating
Data Unavailable
Context Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
contexttherapeutics.com
52-Week Data
52-Week High:
2.45
52-Week Low:
0.49
Prediction Charts
Market Cap:
225.6M
Price in USD:
2.40
Volume:
4M
Beta:
1.88
Technical Analysis
SMA50:
1.34
SMA100:
1.22
SMA200:
0.98
52-Wk Change:
182.35%
Stock Predictions
-
Is Context Therapeutics, Inc. stock public?Yes, Context Therapeutics, Inc. is a publicly traded company.
-
What is the Context Therapeutics, Inc. stock quote today?The Context Therapeutics, Inc. stock price is 2.40 USD today.
-
How to buy Context Therapeutics, Inc. stock online?You can buy Context Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-8 | 1.70 | 1.60 | 1.72 | 1.57 |
| Jan-9 | 1.61 | 1.61 | 1.70 | 1.55 |
| Jan-12 | 1.63 | 1.49 | 1.63 | 1.47 |
| Jan-13 | 1.51 | 1.50 | 1.61 | 1.46 |
| Jan-14 | 1.49 | 1.57 | 1.65 | 1.49 |
| Jan-15 | 1.62 | 1.52 | 1.64 | 1.47 |
| Jan-16 | 1.49 | 1.44 | 1.52 | 1.42 |
| Jan-20 | 1.41 | 1.54 | 1.58 | 1.39 |
| Jan-21 | 1.56 | 1.64 | 1.65 | 1.52 |
| Jan-22 | 1.65 | 1.79 | 1.80 | 1.63 |
| Jan-23 | 1.78 | 1.81 | 1.94 | 1.74 |
| Jan-26 | 1.78 | 2.08 | 2.08 | 1.75 |
| Jan-27 | 2.10 | 2.19 | 2.28 | 1.98 |
| Jan-28 | 2.19 | 2.40 | 2.45 | 2.12 |
Context Therapeutics, Inc. Earnings
Data Unavailable
Context Therapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and an increase next year of $0.01 per share.
* Context Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.